A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

NCT02608476 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
732
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cassiopea SpA